Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medi...(forexample Computed Tomography (CT) and ...)

Date:2/11/2008

for example Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), provide only anatomical or metabolic information; whereas MEG is a direct measure of neuronal electric activity. When complemented with MRI, MEG increases the ability to understand brain activity and to improve treatment of functional disorders and, in particularly, Epilepsy.

"We are extremely excited about our upcoming Magnetoencephalography system installation," said Dr. Sanjay Singh, Director of The Nebraska Epilepsy Center at The Nebraska Medical Center and Associate Professor in the Department of Neurological Sciences at the University of Nebraska Medical Center.

"We plan to use the MEG extensively as a vital part of our pre-surgical epilepsy evaluation. The highly accurate localization capability is exactly what is needed when dealing with complex intractable epilepsy cases," Singh continued. "The Nebraska Medical Center is home to a comprehensive epilepsy program that serves Nebraska and the surrounding region. It provides new hope and opportunities to people with epilepsy with a multi-phase monitoring and treatment program using some of the most advanced diagnostic equipment available. Adding MEG technology will enable our doctors to more accurately pinpoint the site of a seizure and determine the type of epilepsy. The Elekta Neuromag seems ideally suited to helping us to deal with the most difficult to treat epilepsy patients, many of whom do not respond well to medications. Particularly useful is the Elekta technology which will allow us to measure patients that have an implanted vagal nerve stimulator."

"We wish The Nebraska Medical Center every success with the treatment of their patients and hope that the MEG system will provide valuable additional information," said Tomas Puusepp, President and CEO of Elekta. "We are pleased that this technology can make a difference in the quality of patient care, even in difficult cases."

Elekta Neuromag(R)

T
'/>"/>

SOURCE Elekta, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
2. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
3. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
4. Elekta Negotiates To Acquire CMS
5. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
6. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
7. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
8. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
9. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
10. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
11. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability